Prof. Shu Chuen Li
| Work Phone | (02) 4921 5921 |
|---|---|
| Fax | (02) 492 17903 |
| Shuchuen.Li@newcastle.edu.au | |
| Position | Professor School of Biomedical Sciences and Pharmacy |
| Office | MS108, Medical Sciences |
Biography
Professor Shu Chuen Li is Chair Professor and Discipline Convenor, Discipline of Pharmacy and Experimental Pharmacology.
Before taking up the present position, Professor Li has worked as an academic at the National University of Singapore and as Acting Director and Deputy Director, Pharmaceutical Evaluation Section (PES) of Pharmaceutical Benefits Branch, Commonwealth Department of Health & Ageing in Canberra.
During his period in Singapore, besides his academic appointment, Professor Li also served as the Visiting Specialist and Consultant to the Health Sciences Authority (which is the Singaporean equivalent of FDA in the USA and TGA in Australia). In this capacity, Professor Li has been instrumental in developing the Pharmacoeconomics and Drug Utilization Unit at the Centre for Drug Administration, Health Sciences Authority and in organizing several of the first ever pharmaceoconomics and outcomes conferences in the region. In his capacity as Acting Director and Deputy Director of PES in Australia, Professor Li was among the few pioneers that put the principles of pharmacoeconomic evaluation into practice for regulatory affairs, and has been involved in the implementation of the first version of the Australian Pharmacoeconomics Guidelines and the development of the second version of the same Guidelines.
Professor Li has been very active in his research area of pharmacoeconomics and outcomes research as well as pharmacy practice. He has published more than 250 peer review articles and conference abstracts on the subjects. In the past few years, Professor Li has been invited to present more than 100 lectures and panel speeches about pharmacy practice, drug policies and pharmacoeconomic applications in various countries and jurisdictions.
Professor Li was a Director on the ISPOPR Board of Directors from 2006 to 2008, and a founding member of the ISPOR Asia Consortium. Based in the United States, ISPOR is the peak academic society on pharmacoeconomics and outcomes research worldwide.
Besides the aforementioned commitments, Professor Li also holds many other consultative positions in Australia and in various Asian countries. The main ones include:
1. Visiting Professor, Department of Pharmacy, National University of Singapore
2. Visiting Professor, School of Pharmacy, Fudan University, China
3. Visiting Professor, Faculty of Pharmaceutical Science, Prince of Songkla University in Thailand.
4.Visiting Specialist/Consultant, Centre for Drug Administration, Health Sciences Authority, Singapore
5. Visiting Specialist/Consultant, Centre for Health Services Research, Yong Loo Lin School of Medicine, National University of Singapore.
Qualifications
- PhD, Monash University, 1993
- Health Economics (Distance Education), Monash University, 1997
- Master of Business Administration, 1996
- Post Graduate Diploma in Management, Deakin University, 1995
- Master of Applied Science, South Australian Institute of Technology, 1983
- Bachelor of Pharmacy, South Australian Institute of Technology, 1978
Research
Research keywords
- Clinical Pharmacy
- Cost-effectiveness studies
- Drug Policy
- Health economics
- Health services research
- Outcomes Research
- Patient reported outcomes studies
- Pharmacoeconomics
- Pharmacoepidemiology
Research expertise
I have been involved with research in clinical pharmacy for more than 20 years. Recently, my research interest has been concentrated more on the areas of pharmacoeconomics and outcomes research, as well as drug policy. As a matter of fact, I would be considered as one of the pioneers in applying pharmacoeconomics in drug regulation, as I was involved with the first implementation of the first ever published pharmacoeconomics guidelines in drug reimbursement when I worked for the Commonwealth Government in Australia.
Languages
- Cantonese
- English
- Hakka
- Mandarin
Fields of Research
| Description (Code) | % |
|---|---|
| Clinical Sciences(110300) | 45 |
| Public Health And Health Services(111700) | 40 |
| Oncology And Carcinogenesis Not Elsewhere Classified(111299) | 15 |
Appointments
| Board of Directors International Society of Pharmacoeconomics & Outcomes Research (ISPOR) (United States) 01/05/2006 |
| Visiting Professor National University of Singapore (Singapore) 01/04/2007 |
| Visiting Professor Fudan University (China) 01/05/2007 |
Invitations
| 1st National Health Outcomes and Pharmacoeconomics Symposium National University of Singapore, Pfizer Asia and Tan Tock Seng Hospital, Singapore (Chair of theOrganizing Committee) | 2003 |
| . Pre-Conference Workshop, Regional Conference on Cost-effective Healthcare, SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.) | 2004 |
| 15th Annual Scientific Meeting Singapore General Hospital, Singapore (Conference Presentation - non published.) | 2006 |
| 1st National Health Outcomes Conference Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd, Malaysia (Conference Presentation - non published.) | 2004 |
| 1st VALID Study Steering Committee Meeting, Sanofi-Aventis, United Kingdom (Conference Presentation - non published.) | 2003 |
| 21st Federation of Asian Pharmaceutical Associations (FAPA) Congress FAPA, Japan (Conference Presentation - non published.) | 2005 |
| Advanced GCP course on Pharmacovigilance Yong Loo Lin School of Medicine, National University of Singapore, Singapore (Conference Presentation - non published.) | 2006 |
| Asian Pacific Forum on New Therapies in Rheumatic Diseases. National Arthritis Foundation, Singapore (Conference Presentation - non published.) | 2002 |
| Co-sponsor Special Session at ISPOR 2nd Asia Pacific Conference ISPOR & Various regulatory authroities in Asia, China (Conference Presentation - non published.) | 2006 |
| Conference on Quality of Life in Asia Hong Kong Society for Quality of Life, Academy of Medicine, Hong Kong (Conference Presentation - non published.) | 2007 |
| Dinner Symposium: New advances on lipid lowering therapy. Pharmaceutical Society of Singapore, Singapore (Conference Presentation - non published.) | 2003 |
| Health Economic Symposium Vietnamese Ministry of Health & Sanofi-Aventis, Vietnam (Conference Presentation - non published.) | 2005 |
| Health Policy Dinner Symposium Fudan University and Chinese University of Hong Kong , China (Conference Presentation - non published.) | 2007 |
| IMS Special Symposium at ISPOR 2nd Asia Pacific Conference IMS & ISPOR, China (Conference Presentation - non published.) | 2006 |
| International Workshop on Pharmacoeconomics: Indonesian Ministry of Health, Indonesia (Conference Presentation - non published.) | 2002 |
| Intervarsity Symposium Singapore, 17th Singapore Pharmacy Congress Pharmaceutical Society of Singapore & National University of Singapore, Singapore (Conference Presentation - non published.) | 2005 |
| Panel Discussion at ISPOR First Asian Pacific Conference ISPOR, Japan (Conference Presentation - non published.) | 2003 |
| Patient Reported Outcomes for Clinical Research Workshop.17th Singapore Pharmacy Congress Pharmaceutical Society of Singapore, Singapore (Conference Presentation - non published.) | 2005 |
| Pre-Conference Workshop at ISPOR 2nd Asia Pacific Conference ISPOR, China (Conference Presentation - non published.) | 2006 |
| Proceedings of International Congress of Indian Pharmacy Graduate Pharmaceutical Society of India, India (Conference Presentation - non published.) | 2003 |
| Regional Conference on Cost-effective Healthcare SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.) | 2004 |
| Regional Conference on Cost-effective Healthcare, SGH Postgraduate Medical Institute Healthcare Management Development Programme, Singapore (Conference Presentation - non published.) | 2004 |
| Second Regional Conference on Cost-effective Healthcare SingHealth Postgraduate Medical Institute, Singapore (Conference Presentation - non published.) | 2006 |
| TASPOR Annual Health Economics Meeting and Symposium TASPOR, Taiwan (Conference Presentation - non published.) | 2005 |
| Third Annual Scientific Meeting Johor State Department of Health, Malaysia (Conference Presentation - non published.) | 2001 |
| Third International Asian Conference on Cancer Screening Health Promotion Board, Singapore (Conference Presentation - non published.) | 2006 |
| Workshop on Healthcare Financing Pharmaceutical Association of Malaysia, Malaysia (Conference Presentation - non published.) | 2002 |
| Symposium on New Standard for Hepatitis B Management Chapter of Gastroenterologists, College of Physicians, Singapore, Singapore (Dinner symposium) | 2006 |
| Pfizer Global Pharmaceuticals Outcomes Research Training Programme Part 1 Pfizer Asia, Singapore (Invited Training Workshop for Asia-Pacific Region) | 2005 |
| Pfizer Outcomes Research Coordinators of Asia Training Program Part 2 Pfizer Asia, Singapore (Invited Training Workshop for Asia-Pacific Region) | 2005 |
| Training Workshop for National Healthcare Group College National Healthcare Group, Singapore (Invited Workshop) | 2006 |
| COFM Public Health Update Forum Chapter of Public Health & Occupational Physicians, Academy of Medicine, Singapore and Department of Community, Occupational and Family Medicine, Faculty of Medicine, National University of Singapore., Singapore (Invited talk) | 2005 |
| Dinner Symposium of Osteoporosis Society of Singapore Osteoporosis Society of Singapore Special Interest Group Meeting,, Singapore (Invited talk) | 2005 |
| Invited Lecture Kyoto University, Japan (Invited talk) | 2002 |
| Invited Lecture Centre of Pharmaceutical Administration, Health Sciences Authority, Singapore (Invited talk) | 2001 |
| Invited Lecture Institute of Health Economics and Policy, Japan (Invited talk) | 2002 |
| Invited Lecture National Healthcare Group P & T Co-ordinating Committee, Singapore (Invited talk) | 2002 |
| Invited Lecture University of Tokyo, Japan (Invited talk) | 2002 |
| Invited Lecture at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand (Invited talk) | 2004 |
| Invited Talk School of Pharmacy, Fudan University, China (Invited talk) | 2006 |
| Invited Talk Centre for Pharmaceutical Administration, Health Sciences Authority, Singapore (Invited talk) | 2005 |
| Presentation Talk at Science Focus for Teachers Program Ministry of Education & Faculty of Science, National University of Singapore, Singapore (Invited talk) | 2005 |
| Medical Decision Workshop Tan Tock Seng Hospital, Singapore, Institute of Medical Education and Training (IMET), NHG College, Singapore (Invited workshop) | 2004 |
| Post Conference Workshop, 1st National Health Outcomes Conference Association Of Public Health Medical Specialist and Pfizer Malaysia Sdn. Bhd, Malaysia (Invited workshop) | 2004 |
| Pre-conference workshop of ISPOR First Asian Pacific Conference ISPOR, Australia (Invited workshop) | 2003 |
| Pharmacoeconomics for Pharmacists Workshop Pharmaceutical Society of Singapore, Singapore (Invited workshop and Talk) | 2002 |
| Third Asia Pacific Evidence-Based Medicine Conference and Workshop, National University of Singapore & McMaster University of Canada, Singapore (Invited workshop and Talk) | 2005 |
| 15th Singapore Pharmacy Congress Pharmaceutical Society of Singapore, Singapore (Plenary Speech) | 2002 |
| An Evidence Based and Pharmacoeconomic Approach to Drug Prescribign Seminar National University Hospital Pharmacy and Therapeutics Committee, Singapore (Plenary Speech) | 2001 |
| First International Pharmaceutical Students Federation Asian Pacific Symposium IPSF of FIP, Singapore (Plenary Speech) | 2001 |
| 2nd VALID Steering Committee Meeting Sanofi-Aventis, Thailand (Research syposium) | 2004 |
| Roundtable Discussion for Chinese Delegation. ISPOR First Asian Pacific Conference, GSK, Japan (Special Invited Round table discussion) | 2003 |
| Continuous Education Lecture Pharmaceutical Society of Singapore Industry Chapter, Singapore ( ) | 2006 |
| Faculty of Science Lunchtime Seminar Faculty of Science, National University of Singapore, Singapore ( ) | 2006 |
Administrative
Administrative expertise
I have been the acting director and deputy director at one of the Commonwealth Government department in Canberra for around 5 years. Before that I held senior pharmacist position as well as chief pharmacist and chief hospital administrator in Republic of Nauru for a period of 2 years.
During the course of my career, I have been involved in handling many adminsitrative decisions and I have completed a degree of Master of Business Administration to provide the theoretcial consolidation of my administrative experience.
Teaching
Teaching keywords
- Biostatistics
- Clinical Pharmacy Practice
- Critical Literature Evaluation
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacotherapeutics
Teaching expertise
I have been teaching pharmacoeconomics and outcomes research as well as pharmacotherapy for nearly 10 years. I have also been invited to provide lectures and workshops around the South-east Asian region during my period working at the National University of Singapore. I have also conducted courses for critical literature evaluation and biostatistics at the graduate level for nearly 10 years.
Teaching interests
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacy practice
- Pharmacotherapeutics
